文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Discrepancy of Hans' criteria for clonally related nodal and pericardiac fluid diffuse large B-cell lymphoma with MYD88 L265P mutation.

作者信息

Terao Toshiki, Sato Yumiko, Kuroda Yoshiaki, Haratake Tomoka, Nishimura Midori Filiz, Sato Yasuharu, Kuyama Shoichi

机构信息

Department of Hematology, NHO Iwakuni Clinical Center, Iwakuni, Japan.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Medical School, Okayama, Japan.

出版信息

J Clin Exp Hematop. 2024 Dec 25;64(4):318-322. doi: 10.3960/jslrt.24050. Epub 2024 Nov 28.


DOI:10.3960/jslrt.24050
PMID:39603634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11786154/
Abstract

A 79-year-old Japanese woman presented with exertional dyspnea. She had cardiac tamponade and urgent pericardial drainage was performed. Pathological findings from the pericardial fluid revealed non-germinal center B-cell (non-GCB) pericardial large B-cell lymphoma (CD10, BCL6, and MUM1). Although a diagnosis of fluid overload-associated large B-cell lymphoma was considered, GCB nodal diffuse large B-cell lymphoma (CD10, BCL6, and MUM1) was discovered through needle biopsy of the enlarged left axillary lymph node. Despite the two lymphomas exhibiting different expression levels of CD10, polymerase chain reaction assessing IgH gene rearrangement suggested a clonal relationship between them. Additionally, MYD88 L265P mutation was confirmed using Sanger sequencing in both samples, suggesting the MCD type. Our case highlights a discrepancy between the Hans' criteria and the gene expression profile-based cell of origin.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd35/11786154/07cf158bf4b6/jslrt-64-318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd35/11786154/652181ffa4a8/jslrt-64-318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd35/11786154/07cf158bf4b6/jslrt-64-318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd35/11786154/652181ffa4a8/jslrt-64-318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd35/11786154/07cf158bf4b6/jslrt-64-318-g002.jpg

相似文献

[1]
Discrepancy of Hans' criteria for clonally related nodal and pericardiac fluid diffuse large B-cell lymphoma with MYD88 L265P mutation.

J Clin Exp Hematop. 2024-12-25

[2]
Comparison of the Lymph2Cx Assay and Hans Algorithm in Determining the Cell-of-Origin of Diffuse Large B-Cell Lymphomas, Not Otherwise Specified.

Appl Immunohistochem Mol Morphol. 2020

[3]
CD79B and MYD88 mutations in diffuse large B-cell lymphoma.

Hum Pathol. 2013-10-31

[4]
Diffuse large B-cell lymphoma with composite germinal center and non-germinal center types: A report of two cases.

J Clin Exp Hematop. 2023-9-28

[5]
Clinicopathological Analysis of 320 Cases of Diffuse Large B-cell Lymphoma Using the Hans Classifier.

J Clin Exp Hematop. 2017

[6]
Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.

Sci Rep. 2017-5-11

[7]
CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.

Cancer Cytopathol. 2016-2

[8]
Expression of MYD88 L265P Mutation in Subtypes of Diffuse Large B-Cell Lymphoma in the Pakistani Population.

Appl Immunohistochem Mol Morphol. 2025-1-1

[9]
MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.

Hum Pathol. 2013-2-4

[10]
[CD5- and CD10-positive MYC and BCL2 double-expressor diffuse large B-cell lymphoma with MYD88 mutation: a case report and literature review].

Rinsho Ketsueki. 2023

引用本文的文献

[1]
An aggressive case of Fluid overload-associated large B-cell lymphoma (FO-LBCL) with CD20 down-regulation.

J Clin Exp Hematop. 2025

本文引用的文献

[1]
Heterogeneity or change in cell of origin in diffuse large B-cell lymphomas determined using hans algorithm.

Hum Pathol. 2024-9

[2]
B-cell non-Hodgkin lymphomas.

Lancet. 2024-5-4

[3]
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial.

Cancer Cell. 2023-10-9

[4]
Diffuse large B-cell lymphoma with composite germinal center and non-germinal center types: A report of two cases.

J Clin Exp Hematop. 2023-9-28

[5]
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Leukemia. 2022-7

[6]
A single-cell atlas of diffuse large B cell lymphoma.

Cell Rep. 2022-4-19

[7]
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.

N Engl J Med. 2022-1-27

[8]
Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.

Cancer Cell. 2021-12-13

[9]
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements.

Blood Adv. 2022-4-12

[10]
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces.

EBioMedicine. 2020-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索